At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 236 enrolled
Drug / intervention
Telemedical blood pressure monitoringdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Comparison of Telemedical and Conventional Antihypertensive Treatment
In Brief
A Phase 4 clinical trial evaluating Telemedical blood pressure monitoring for Hypertension. Completed, enrolled 236 participants across 1 site.
Detailed Summary
The aim of the study is to compare telemedical antihypertensive treatment based on home blood pressure monitoring and conventional antihypertensive treatment based on monitoring of blood pressure in the doctor's office. We want to test the hypotheses that telemedical treatment is more effective in lowering blood pressure, provide better quality of life and is more cost-effective.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesDenmark
Collaborators--
Timeline
Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2004
First PostedJan 2006
Primary CompletionDec 2008
TodayJul 2026
First PostedJan 26, 2006
Enrollment StartMay 1, 2004
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 20.4 years ago
Interventions
Telemedical blood pressure monitoringdevice
Measurement of home blood pressure, three times per week for three months and once a week for three months.